The lawsuit accuses Eli Lilly of misleading consumers by using outdated clinical trial data to make Zepbound and Mounjaro appear more effective than Novo's drugs, Wegovy and Ozempic, for weight loss and Type 2 diabetes treatment
[DOI] [PubMed] [Google Scholar] 50.Nordio M., Basciani S
The efficacy of drugs like Mounjaro can depend on a number of different factors, including diet and exercise habits, individual metabolisms, starting weight, and consistency with taking the medication
PLOS ONE 13 , e0203946 (2018)
A 2025 systematic review identified 544 total articles on BPC-157 published between 1993 and 2024, but after applying inclusion criteria, only 36 studies remained eligible for analysis
The role of osteokines in sarcopenia: Therapeutic directions and application prospects